All lobbying filings
BROWNSTEIN HYATT FARBER SCHRECK, LLP
BROWNSTEIN HYATT FARBER SCHRECK, LLP filed a Q4 report for NOVAVAX, INC. on January 16, 2026, reporting $50,000 in lobbying income.
Lobbying for NOVAVAX, INC. · Biotechnology company
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 16, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Maryland
Government bodies contacted
2
Lobbying activity
1
Issues related to federal vaccine programs and vaccine regulatory frameworks. FDA funding and advocacy